{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:44:47Z","timestamp":1769150687143,"version":"3.49.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the intention of coronavirus disease 2019 (COVID-19) vaccination in Korean patients with myasthenia gravis (MG) and to determine the factors that influence their attitude toward COVID-19 vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We conducted a questionnaire survey of 160 Korean patients with MG. The questionnaire consisted of five categories, including vaccination status, willingness to get vaccinated, general concerns over vaccination, impact of MG diagnosis on vaccination decision, and MG-specific concerns over vaccination. The responses were rated from 1 (no intention or influence) to 5 (significant intention or influence). We compared the clinical factors between patients willing to get vaccinated (willing group) and those who were neutral or unwilling (hesitant group).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The average score of willingness to get vaccinated was 4.1 \u00b1 1.2 (Likert score, 1\u20135). The hesitant group demonstrated higher proportions of women, patients with MG Foundation of America (MGFA) classification \u2265III at nadir, and those who had experienced myasthenic crisis than the willing group (women, <jats:italic>p<\/jats:italic> = 0.027; MGFA classification\u2265III, <jats:italic>p<\/jats:italic> = 0.018; myasthenic crisis, <jats:italic>p<\/jats:italic> = 0.027). Scores for the willingness to get vaccinated (Likert score, 1\u20135) were negatively correlated with the MGFA classification at nadir (<jats:italic>r<\/jats:italic> = \u22120.235, <jats:italic>p<\/jats:italic> = 0.003), degree of general concern about vaccination (<jats:italic>r<\/jats:italic> = \u22120.362, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), and impact of MG diagnosis on vaccination decision (<jats:italic>r<\/jats:italic> = \u22120.365, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). In the path analysis, the MGFA classification at nadir was negatively associated with the willingness to get vaccinated by increasing the impact of MG diagnosis on vaccination decision.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MG diagnosis, maximum disease severity, and general concerns about vaccination influenced the intention to get vaccinated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.847873","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T09:21:29Z","timestamp":1659691289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors affecting the intention of COVID-19 vaccination in Korean patients with myasthenia gravis: A survey-based study"],"prefix":"10.3389","volume":"13","author":[{"given":"Sooyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41582-020-0385-8","article-title":"Neurological immunotherapy in the era of COVID-19\u2014looking for consensus in the literature","volume":"16","author":"Korsukewitz","year":"2020","journal-title":"J Nature reviews Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104357","DOI":"10.1016\/j.jcv.2020.104357","article-title":"Epidemiology and clinical features of COVID-19: a review of current literature","volume":"127","author":"Siordia Jr","year":"2020","journal-title":"J Clinical Virology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J Journal of Neuroimmune Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.21.21262927","article-title":"Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26","author":"Barbeau","year":"2021","journal-title":"COV2 S J medRxiv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"J Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","article-title":"Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups","volume":"16","author":"Boey","year":"2020","journal-title":"J Human Vaccines Immunotherapeutics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/vaccines9020077","article-title":"Knowledge, attitudes and practices of Flu vaccination in hemodialysis patients","volume":"9","author":"Gawry\u015b","year":"2021","journal-title":"J Vaccines."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/847393","article-title":"Myasthenia gravis: a review of available treatment approaches","author":"Gilhus","year":"2011","journal-title":"J Autoimmune Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"J Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"J Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: An R Package for Structural Equation Modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J Statistical Software."},{"key":"B12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","article-title":"Comparative fit indexes in structural models","volume":"107","author":"Bentler","year":"1990","journal-title":"Psychol Bull."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct Equa Model: Multidisciplinary J."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15368","article-title":"COVID-19 vaccination hesitancy among people with chronic neurological disorders: a position paper","author":"Rakusa","year":"2022","journal-title":"J European journal of neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1016\/j.vaccine.2011.06.107","article-title":"Factors associated with uptake of vaccination against pandemic influenza: a systematic review","volume":"29","author":"Bish","year":"2011","journal-title":"J Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/annrheumdis-2021-220059","article-title":"SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists","volume":"80","author":"Priori","year":"2021","journal-title":"J Annals of the Rheumatic Diseases."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102788","DOI":"10.1016\/j.msard.2021.102788","article-title":"Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States","volume":"49","author":"Ehde","year":"2021","journal-title":"J Multiple Sclerosis Related Disorders."},{"key":"B18","doi-asserted-by":"publisher","first-page":"717111","DOI":"10.3389\/fneur.2021.717111","article-title":"COVID-19 vaccination attitudes with neuromyelitis optica spectrum disorders: vaccine hesitancy and coping style","volume":"12","author":"Xu","year":"2021","journal-title":"J Front Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/idr13030072","article-title":"Variables associated with coronavirus disease 2019 vaccine hesitancy amongst patients with neurological disorders","volume":"13","author":"Ghaffari-Rafi","year":"2021","journal-title":"J Infectious Dis Reports."},{"key":"B20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10067-020-05059-7","article-title":"Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review","volume":"40","author":"Boucher","year":"2021","journal-title":"J Clinical rheumatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1002\/hsr2.469","article-title":"Patients' attitude towards vaccination after Guillain Barr\u00e9 syndrome","volume":"4","author":"Holtz","year":"2021","journal-title":"J Health Science Reports."},{"key":"B22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/13548506.2020.1807577","article-title":"Post-traumatic stress disorder symptoms after respiratory insufficiency in patients with myasthenia gravis","volume":"26","author":"Liu","year":"2021","journal-title":"J Psychology, Health Medicine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-019-2489-3","article-title":"Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis","volume":"23","author":"Righy","year":"2019","journal-title":"J Critical Care."},{"key":"B24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jpepsy\/jsab043","article-title":"The Role of Trauma in Mothers' COVID-19 vaccine beliefs and intentions","volume":"46","author":"Milan","year":"2021","journal-title":"J Pediatric Psychol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"Jacob","year":"2020","journal-title":"J Journal Neurolo Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/vaccines9101112","article-title":"COVID-19 vaccination in patients with myasthenia gravis: a single-center case series","volume":"9","author":"Ruan","year":"2021","journal-title":"J Vaccines."},{"key":"B27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mus.27497","article-title":"Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19","volume":"65","author":"Gungor Tuncer","year":"2022","journal-title":"J Muscle Nerve."},{"key":"B28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"J Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/vaccines8040582","article-title":"Influences on attitudes regarding potential COVID-19 vaccination in the United States","volume":"8","author":"Pogue","year":"2020","journal-title":"J Vaccines."},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5603\/PJNNS.a2021.0054","article-title":"COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study","volume":"56","author":"Rzepi\u0144ski","year":"2022","journal-title":"J Neurologia i Neurochirurgia Polska."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000011669","article-title":"Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis","volume":"96","author":"Sol\u00e9","year":"2021","journal-title":"J Neurology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0246970","DOI":"10.1371\/journal.pone.0246970","article-title":"Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US","volume":"16","author":"Latkin","year":"2021","journal-title":"J PloS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41562-021-01056-1","article-title":"Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA","volume":"5","author":"Loomba","year":"2021","journal-title":"J Nature Human Behav."},{"key":"B34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/vaccines9030300","article-title":"Factors associated with COVID-19 vaccine hesitancy","volume":"9","author":"Soares","year":"2021","journal-title":"J Vaccines."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.847873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T09:21:31Z","timestamp":1659691291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.847873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":34,"alternative-id":["10.3389\/fneur.2022.847873"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.847873","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"article-number":"847873"}}